Access cutting-edge renal cell carcinoma treatment through this clinical trial at a research site in Lone Tree. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Lone Tree location
Preparing your pre-screening questions…
Access renal cell carcinoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related renal cell carcinoma treatment provided free
Check if you qualify for this renal cell carcinoma clinical trial in Lone Tree, CO
No-Cost Study Care
Local to Lone Tree
Convenient for CO residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a Phase 1b, open-label, multicenter, safety, tolerability and efficacy study of HC-7366 in combination with belzutifan (WELIREG™). This is a multipart study that consists of a HC-7366 monotherapy cohort, a combination dose escalation, and a combination dose expansion. Approximately 80 patients will be enrolled in this study (up to 20 patients will be enrolled into the HC-7366 monotherapy cohort, up to 30 patients into the combination dose escalation, and up to 30 patients into the combination dose expansion). The primary purpose of this study is to determine the maximum tolerated dose of HC-7366 in combination with belzutifan in patients with locally advanced (inoperable) or metastatic RCC with predominantly clear cell histology, irrespective of VHL gene mutation status.
Sponsor: HiberCell, Inc.
Yes, this clinical trial (NCT06234605) has an active research site in Lone Tree, CO that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for renal cell carcinoma treatment options in Lone Tree, CO, this clinical trial (NCT06234605) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lone Tree research site is actively enrolling participants for this clinical trial. You'll receive care from experienced renal cell carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all renal cell carcinoma clinical trials near you to find additional studies recruiting in your area.
See all kidney cancer clinical trials recruiting in Lone Tree — not just this study.
Browse Kidney Cancer Trials in Lone Tree →